Company / Current Assets per Share
Sana Biotechnology, Inc. Current Assets per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.70
FY2024
5-year range
$0.70 / $29.54
FY2020-FY2024
Trend
-36.5%
vs FY2023
Sector context
#203 of 210
Health Care
What the data says
Among 210 Health Care companies, Sana Biotechnology, Inc. is in the bottom 3% for current assets per share. Current Assets per Share has declined for 4 consecutive years, from $29.54 in FY2020 to $0.70 in FY2024.
Based on SEC 10-K filings.
0.70 in FY2024 with a 3-year CAGR of -40.8%.
Declined from $2.36 to $0.70 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -40.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 210This company $0.70 Sector average $170.65
▼
-99.6% below sector average
Key checks
Key Insights
- Sana Biotechnology, Inc.'s current assets per share has declined for 4 consecutive years.
- In FY2024, current assets per share decreased 36.5% year-over-year.
- Ranks #203 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.70 | -36.5% |
| FY2023 | $1.10 | -53.5% |
| FY2022 | $2.36 | -29.6% |
| FY2021 | $3.35 | -88.6% |
| FY2020 | $29.54 | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026